查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371973

2030 年生物材料市场预测：按类型、应用和地区分類的全球分析

Biomaterials Market Forecasts to 2030 - Global Analysis By Type, By Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球生物材料市场规模为1,801亿美元，预计2030年将达到5,153亿美元，预测期内复合年增长率为16.2%。

生物材料是专为医疗和保健应用而设计的专用材料，可与生物系统相互作用，以帮助诊断、治疗和组织修復。这些材料被设计为具有生物相容性，可以与身体无缝整合，不会造成伤害或副作用。生物材料包括多种材料，包括金属、聚合物、陶瓷和复合材料，并用于各种医疗设备、植入物、药物传输系统和组织工程。

根据世界卫生组织 (WHO) 2022 年 3 月的更新，恆牙龋齿影响全球估计 20 亿人，乳牙龋齿年度影响 5.2 亿儿童。我是。

对植入设备的需求增加

随着社会不断高龄化，对整形外科植入物、心血管支架等医疗设备的需求也不断增加。生物材料在提高这些设备的生物相容性和使用寿命方面发挥着至关重要的作用。此外，微创手术技术的进步正在扩大植入式医疗设备的范围并提高普及。由于需要手术介入的慢性疾病盛行率不断上升，对生物材料的需求进一步增加。因此，生物材料市场持续扩大，因为植入式医疗设备在改善患者生活品质方面发挥关键作用。

严格的临床和法规流程

医用生物材料的开发和商业化需要广泛的临床试验并遵守严格的法规指南，导致研究上市时间较长和大量投资。这将会是。这些确保安全性和有效性的流程可以防止小型企业因高昂的合规成本而进入市场。此外，法规障碍可能会导致现有生物材料製造商的延误和成本增加。虽然对病人安全至关重要，但这些严格的要求限制了创新和市场进入的速度，阻碍了新型生物材料快速引入医疗保健领域。

新兴国家医疗保健市场的成长

随着医疗保健服务的改善和可支配所得的增加，这些地区对先进医疗方法和医疗设备（包括依赖生物材料的设备）的需求正在迅速增加。随着医疗保健基础设施的扩大，整形外科、心血管治疗和组织工程对生物材料的需求不断增加。这为生物材料製造商提供了一个巨大的市场，可以满足未满足的医疗需求，促进研究合作，并提供适合这些新兴国家医疗保健系统需求的经济高效的解决方案。这使得生物材料公司能够开拓新市场并帮助改善新兴国家的医疗保健。

缺乏熟练的外科医生

熟练的手术技术和实践对于生物材料的成功应用至关重要。然而，缺乏训练有素、经验丰富的外科医生可能会阻碍生物材料在从移植到组织工程等各种医疗手术中的有效利用。这种限制可能导致患者预后不佳、併发症、效率低下，并影响生物材料在医疗保健领域的声誉。应对这一威胁需要对医学教育和培训计划进行投资，以确保有足够数量的熟练外科医生具备使用生物材料的能力，使他们能够最大限度地发挥潜力并改善患者照护。

COVID-19 的影响：

COVID-19大流行对生物材料产业产生了重大影响。一方面，由于对人工呼吸器、个人防护设备（PPE）和诊断工具等医疗用品和设备的迫切需求，对生物材料的需求激增。生物材料在这些医疗保健必需品的开发和製造中发挥了重要作用。同时，疫情扰乱了全球供应链，导致生物材料的生产和分销延迟。生物材料领域的临床试验和研究项目也受到影响。随着世界各地努力应对这场流行病，业界的应对措施是优先考虑用于疫苗开发和诊断的生物材料研究，进一步凸显了该领域对公共卫生的重要性。

金属基生物材料产业预计将在预测期内成为最大的产业

金属基生物材料在生物材料市场中占有很大份额。这些材料具有高强度、耐用性和耐腐蚀，使其成为整形外科植入物（例如人工关节和牙科用装置）和心血管支架等应用的理想选择。金属生物材料通常由钛和不銹钢等材料製成，具有优异的机械性能，可确保人体内的寿命和稳定性。在提供强大的结构支援的同时，在其设计和开发中考虑生物相容性和减少潜在的过敏反应至关重要，这使得金属生物材料成为医疗治疗和手术进步的关键推动者。您可以做出巨大的贡献。

整形外科预计在预测期内年复合成长率最高

在预测期内，生物材料市场年复合成长率最高的是整形外科领域。金属、聚合物、陶瓷和复合材料等生物材料经过精心设计，可替换或修復受损或退化的骨骼、关节和韧带。它广泛用于各种整形外科器械，包括人工关节（例如髋关节和膝关节）、接骨板和螺丝。生物相容性、机械强度和耐磨性是整形外科生物材料的重要特性，可确保植入物的使用寿命和有效性。整形外科生物材料的进步显着改善了整形外科疾病患者的生活质量，并已成为整形外科护理的重要组成部分。

比最大的地区

北美占据重要地位，预计在预测期内将占据最大份额。该地区在医疗和牙科领域拥有强大的影响力，推动了对各种应用的生物材料的需求，包括整形外科、心血管和人工植牙。此外，对技术进步的重视以及对生物材料优势的认识不断提高也推动了创新和市场成长。严格的法规准则也有助于产品品质和安全。北美仍然是全球生物材料市场的主要企业，重点关注医疗进步和改善患者治疗结果。

复合年复合成长率最高的地区：

由于医疗保健部门的快速扩张、研发投资的增加以及老年人口的不断增长，亚太地区的生物材料市场年复合成长率最高。该地区慢性病盛行率不断上升，加上中阶人口不断增长，正在推动整形外科、心血管和创伤治疗等应用领域对生物材料的需求。此外，先进医疗技术的采用和医疗保健成本的上升正在推动生物材料在创新医疗设备和植入物中的使用。亚太地区对全球生物材料市场做出了重大贡献，为国内外生物材料公司提供了巨大的成长潜力和机会。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的竞争关係

第5章全球生物材料市场：依类型

  • 金属生物材料
    • 不銹钢
    • 钛及钛合金
    • 钴铬合金
    • 钱
    • 银
    • 镁
  • 高分子生物材料
    • 聚甲基丙烯酸甲酯
    • 聚乙烯
    • 聚酯纤维
    • 硅橡胶
    • 尼龙
    • 聚醚醚酮
    • 其他高分子生物材料
  • 陶瓷
    • 磷酸钙
    • 氧化锆
    • 氧化铝
    • 硫酸钙
    • 碳
    • 玻璃
  • 天然生物材料
    • 玻尿酸
    • 胶原
    • 明胶
    • 纤维蛋白
    • 纤维素
    • 厨房
    • 藻酸盐
    • 丝绸

第6章全球生物材料市场：依应用分类

  • 心血管
    • 支架
    • 植入式心臟整流去颤器
    • 起搏器
    • 心臟瓣膜
    • 血管移植物
  • 整形外科
    • 关节重建手术
      • 关节重建
      • 髋关节置换术
      • 肩关节置换术
    • 关节内粘稠补充疗法
    • 生物可吸收组织的固定
      • 缝合锚钉
      • 紧固螺丝
      • 半月软骨修復螺柱
      • 网
    • 脊椎
      • 脊椎融合手术
      • 微创融合手术
      • 运动保留手术及动态稳定化手术
    • 骨折固定装置
      • 骨板
      • 拧紧
      • 别针
      • 桿
      • 金属丝
    • 合成骨移植物
  • 眼科
    • 隐形眼镜
      • 人工水晶体
      • 眼组织的功能性替代
      • 人工角膜
  • 牙科
    • 人工植牙
    • 牙科骨移植片和替代
    • 牙膜
    • 组织再生
  • 整形外科
    • 软组织填充剂
    • 颅颜手术
  • 创伤治疗
    • 伤口缝合装置
    • 手术止血器
    • 内部组织密封胶
    • 黏附屏障
    • 疝气网
  • 人体组织工程
    • 再生医学支架
    • 生物感
    • 无机奈米粒子的製备
  • 神经系统/中枢神经系统的应用
    • 分流系统
    • 皮质神经假体
    • 用于中枢神经系统修復的水凝胶支架
    • 神经干细胞封装
  • 其他用途
    • 药物输送系统
    • 胃肠道应用
    • 减重手术
    • 泌尿系统的应用

第7章全球生物材料市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第8章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第9章公司简介

  • Corbion NV
  • Royal DSM
  • Noble Biomaterials Inc.
  • Covalon Technologies Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Linden Capital Partners（Collagen Matrix, Inc.）
  • Stryker Corporation（Wright Medical Group NV）
  • Victrex Plc
  • Evonik Industries
  • Carpenter Technology Corporation
  • Medtronic plc
  • Berkeley Advanced Biomaterials
Product Code: SMRC24029

According to Stratistics MRC, the Global Biomaterials Market is accounted for $180.1 billion in 2023 and is expected to reach $515.3 billion by 2030 growing at a CAGR of 16.2% during the forecast period. Biomaterials are specialized materials designed for use in medical and healthcare applications, where they interact with biological systems to aid in diagnostics, treatment, or tissue repair. These materials are engineered to be biocompatible, meaning they can integrate seamlessly with the body without causing harm or adverse reactions. Biomaterials encompass a wide range of substances, including metals, polymers, ceramics, and composites, and are used in various medical devices, implants, drug delivery systems, and tissue engineering.

According to the March 2022 update of the World Health Organization, caries of permanent teeth affect an estimated 2 billion individuals worldwide, while caries of primary teeth affect 520 million children annually.

Market Dynamics:

Driver:

Increasing demand for implantable devices

As the aging population grows, so does the need for medical devices like orthopedic implants and cardiovascular stents. Biomaterials play a pivotal role in enhancing the biocompatibility and longevity of these devices. Moreover, advancements in minimally invasive surgical techniques have expanded the range of implantable medical devices, increasing their prevalence. The demand for biomaterials is further driven by the rising incidence of chronic diseases that require surgical interventions. As a result, the biomaterials market continues to expand, driven by the critical role it plays in improving the quality of life for patients requiring implantable medical devices.

Restraint:

Stringent clinical & regulatory processes

The development and commercialization of biomaterials for medical applications require extensive clinical testing and adherence to stringent regulatory guidelines, leading to prolonged research-to-market timelines and significant financial investments. These processes, intended to ensure safety and efficacy, can deter smaller companies from entering the market due to high compliance costs. Additionally, regulatory hurdles may result in delays and increased expenses for established biomaterial manufacturers. While essential for patient safety, these strict requirements limit the speed of innovation and market entry, thereby hindering the rapid introduction of novel biomaterials into the healthcare sector.

Opportunity:

Growing healthcare market in emerging economies

With improving access to healthcare and rising disposable incomes, these regions are witnessing a surge in demand for advanced medical treatments and devices, including those reliant on biomaterials. As healthcare infrastructure expands the need for biomaterials in orthopedics, cardiovascular treatments, and tissue engineering rises. This offers a substantial market for biomaterial manufacturers to address unmet medical needs, foster research collaborations, and provide cost-effective solutions tailored to the demands of these developing healthcare systems. It positions biomaterial companies to tap into new markets and contribute to enhanced medical care in emerging economies.

Threat:

Shortage of skilled surgeons

The successful application of biomaterials often relies on proficient surgical techniques and practices. However, a shortage of well-trained and experienced surgeons can hinder the effective utilization of biomaterials in various medical procedures, from implantations to tissue engineering. This limitation may lead to suboptimal patient outcomes, complications, and inefficiencies, affecting the reputation of biomaterials in healthcare. Addressing this threat requires investments in medical education and training programs to ensure that an adequate number of skilled surgeons are available to work with biomaterials, maximizing their potential and expanding their positive impact in patient care.

COVID-19 Impact:

The COVID-19 pandemic has had a notable impact on the biomaterials industry. On one hand, the demand for biomaterials surged in response to the urgent need for medical supplies and equipment, such as ventilators, personal protective equipment (PPE), and diagnostic tools. Biomaterials played a critical role in developing and manufacturing these healthcare essentials. On the other hand, the pandemic disrupted global supply chains, leading to delays in production and distribution of biomaterials. Clinical trials and research projects in the biomaterials sector were also affected. As the world grappled with the pandemic, the industry adapted by prioritizing research on biomaterials for vaccine development and diagnostics, further highlighting the sector's importance in public health.

The metallic biomaterials segment is expected to be the largest during the forecast period

The metallic biomaterials have a significant share in the Biomaterials market. These materials exhibit high strength, durability, and corrosion resistance, making them ideal for applications like orthopedic implants (e.g., joint replacements and dental fixtures) and cardiovascular stents. Metallic biomaterials, often made of materials such as titanium and stainless steel, offer excellent mechanical properties, ensuring longevity and stability within the human body. While they provide robust structural support, considerations for biocompatibility and the reduction of potential allergic reactions are essential in their design and development, allowing metallic biomaterials to contribute significantly to the advancement of medical treatments and procedures.

The orthopaedic segment is expected to have the highest CAGR during the forecast period

The orthopaedic has the highest CAGR within the Biomaterials market over the forecast period. These biomaterials, such as metals, polymers, ceramics, and composites, are carefully engineered to replace or repair damaged or degenerated bones, joints, and ligaments. They are employed in a wide range of orthopedic devices, including artificial joints (such as hip and knee replacements), bone plates, and screws. Biocompatibility, mechanical strength, and wear resistance are key attributes in orthopedic biomaterials to ensure the longevity and effectiveness of implants. Advancements in orthopedic biomaterials have significantly improved the quality of life for patients with orthopedic conditions, making them a vital component of orthopedic medicine.

Region with largest share:

North America holds a significant position and expected to hold a largest share over the forecast period. The region's robust presence in the medical and dental fields drives the demand for biomaterials used in various applications, such as orthopedics, cardiovascular, and dental implants. Furthermore, an emphasis on technological advancements, coupled with increasing awareness of the benefits of biomaterials, fuels innovation and market growth. Stringent regulatory guidelines also contribute to product quality and safety. North America continues to be a key player in the global biomaterials market, with a strong focus on medical advancements and improving patient outcomes.

Region with highest CAGR:

The Asia-Pacific region witnessed the highest CAGR in the Biomaterials market, driven by its rapidly expanding healthcare sector, increasing investments in research and development, and a growing geriatric population. The region's rising incidence of chronic diseases, coupled with a burgeoning middle-class population, fuels the demand for biomaterials in applications like orthopedics, cardiovascular, and wound healing. Additionally, the adoption of advanced medical technologies and increasing healthcare expenditure drive the use of biomaterials for innovative medical devices and implants. Asia-Pacific as a significant contributor to the global biomaterials market, with substantial growth potential and opportunities for both domestic and international biomaterial companies.

Key players in the market:

Some of the key players in Biomaterials Market include: Corbion N.V, Royal DSM, Noble Biomaterials Inc., Covalon Technologies Ltd., Zimmer Biomet Holdings, Inc., Stryker Corporation (Wright Medical Group N.V), Victrex Plc, Evonik Industries, Carpenter Technology Corporation, Medtronic plc, Berkeley Advanced Biomaterials and Collagen Matrix.

Key Developments:

In June 2023, Covation Biomaterials, a worldwide provider of bio-based solutions, emerged as an independent business after the Huafon Group acquired DuPont Biomaterials.

In December 2022, Orthopedics Inc., and Invibio Biomaterial Solutions made an announcement of the successful initiation of the study and implantation for the total knee arthroplasty (TKA) on the very first patients with the new polymer, PEEK-OPTIMA™ femoral knee component. This component offers surgeons and patients a femoral component that has the ability to correct component to bone material mismatch.

In May 2022, DuPont announced the launch of a new spun yarn collection in collaboration with JP Modatex India, blending natural fibers with DuPont Sorona staple fibers. The collection combines linen and partially plant-based Sorona fibers to create spun yarns suitable for various applications, such as dresses, shirting, pants and skirts, denim, and jackets.

Types Covered:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramics
  • Natural Biomaterials

Applications Covered:

  • Cardiovascular
  • Orthopaedic
  • Ophthalmology
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurological/Central Nervous System Applications
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biomaterials Market, By Type

  • 5.1 Introduction
  • 5.2 Metallic Biomaterials
    • 5.2.1 Stainless Steel
    • 5.2.2 Titanium & Titanium Alloys
    • 5.2.3 Cobalt-Chrome Alloys
    • 5.2.4 Gold
    • 5.2.5 Silver
    • 5.2.6 Magnesium
  • 5.3 Polymeric Biomaterials
    • 5.3.1 Polymethylmethacrylate
    • 5.3.2 Polyethylene
    • 5.3.3 Polyester
    • 5.3.4 Silicone Rubber
    • 5.3.5 Nylon
    • 5.3.6 Polyetheretherketone
    • 5.3.7 Other Polymeric Biomaterials
  • 5.4 Ceramics
    • 5.4.1 Calcium Phosphate
    • 5.4.2 Zirconia
    • 5.4.3 Aluminum Oxide
    • 5.4.4 Calcium Sulfate
    • 5.4.5 Carbon
    • 5.4.6 Glass
  • 5.5 Natural Biomaterials
    • 5.5.1 Hyaluronic Acid
    • 5.5.2 Collagen
    • 5.5.3 Gelatin
    • 5.5.4 Fibrin
    • 5.5.5 Cellulose
    • 5.5.6 Chitin
    • 5.5.7 Alginates
    • 5.5.8 Silk

6 Global Biomaterials Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiovascular
    • 6.2.1 Stents
    • 6.2.2 Implantable Cardiac Defibrillators
    • 6.2.3 Pacemakers
    • 6.2.4 Heart Valves
    • 6.2.5 Vascular Grafts
  • 6.3 Orthopaedic
    • 6.3.1 Joint Replacement
      • 6.3.1.1 Knee Replacement
      • 6.3.1.2 Hip Replacement
      • 6.3.1.3 Shoulder Replacement
    • 6.3.2 Viscosupplementation
    • 6.3.3 Bioresorbable Tissue Fixation
      • 6.3.3.1 Suture Anchors
      • 6.3.3.2 Interference Screws
      • 6.3.3.3 Meniscal Repair Tacks
      • 6.3.3.4 Meshes
    • 6.3.4 Spine
      • 6.3.4.1 Spinal Fusion Surgeries
      • 6.3.4.2 Minimally Invasive Fusion Surgeries
      • 6.3.4.3 Motion Preservation & Dynamic Stabilization Surgeries
    • 6.3.5 Fracture Fixation Devices
      • 6.3.5.1 Bone Plates
      • 6.3.5.2 Screws
      • 6.3.5.3 Pins
      • 6.3.5.4 Rods
      • 6.3.5.5 Wires
    • 6.3.6 Synthetics Bone Grafts
  • 6.4 Ophthalmology
    • 6.4.1 Contact Lenses
      • 6.4.1.1 Intraocular Lenses
      • 6.4.1.2 Functional Replacement of Ocular Tissues
      • 6.4.1.3 Synthetic Corneas
  • 6.5 Dental
    • 6.5.1 Dental Implants
    • 6.5.2 Dental Bone Grafts & Substitutes
    • 6.5.3 Dental Membranes
    • 6.5.4 Tissue Regeneration
  • 6.5 Plastic Surgery
    • 6.5.1 Soft-Tissue Fillers
    • 6.5.2 Craniofacial Surgery
  • 6.6 Wound Healing
    • 6.6.1 Wound Closure Devices
    • 6.6.2 Surgical Hemostats
    • 6.6.3 Internal Tissue Sealants
    • 6.6.4 Adhesion Barriers
    • 6.6.5 Hernia Meshes
  • 6.7 Tissue Engineering
    • 6.7.1 Scaffolds for Regenerative Medicine
    • 6.7.2 Biosensing
    • 6.7.3 Tailoring of Inorganic Nanoparticles
  • 6.8 Neurological/Central Nervous System Applications
    • 6.8.1 Shunting Systems
    • 6.8.2 Cortical Neural Prosthetics
    • 6.8.3 Hydrogel Scaffolds for CNS Repair
    • 6.8.4 Neural Stem Cell Encapsulation
  • 6.9 Other Applications
    • 6.9.1 Drug Delivery Systems
    • 6.9.2 Gastrointestinal Applications
    • 6.9.3 Bariatric Surgery
    • 6.9.4 Urinary Applications

7 Global Biomaterials Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Corbion N.V
  • 9.2 Royal DSM
  • 9.3 Noble Biomaterials Inc.
  • 9.4 Covalon Technologies Ltd.
  • 9.5 Zimmer Biomet Holdings, Inc.
  • 9.6 Linden Capital Partners (Collagen Matrix, Inc.)
  • 9.7 Stryker Corporation (Wright Medical Group N.V)
  • 9.8 Victrex Plc
  • 9.9 Evonik Industries
  • 9.10 Carpenter Technology Corporation
  • 9.11 Medtronic plc
  • 9.12 Berkeley Advanced Biomaterials

List of Tables

  • Table 1 Global Biomaterials Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Biomaterials Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Biomaterials Market Outlook, By Metallic Biomaterials (2021-2030) ($MN)
  • Table 4 Global Biomaterials Market Outlook, By Stainless Steel (2021-2030) ($MN)
  • Table 5 Global Biomaterials Market Outlook, By Titanium & Titanium Alloys (2021-2030) ($MN)
  • Table 6 Global Biomaterials Market Outlook, By Cobalt-Chrome Alloys (2021-2030) ($MN)
  • Table 7 Global Biomaterials Market Outlook, By Gold (2021-2030) ($MN)
  • Table 8 Global Biomaterials Market Outlook, By Silver (2021-2030) ($MN)
  • Table 9 Global Biomaterials Market Outlook, By Magnesium (2021-2030) ($MN)
  • Table 10 Global Biomaterials Market Outlook, By Polymeric Biomaterials (2021-2030) ($MN)
  • Table 11 Global Biomaterials Market Outlook, By Polymethylmethacrylate (2021-2030) ($MN)
  • Table 12 Global Biomaterials Market Outlook, By Polyethylene (2021-2030) ($MN)
  • Table 13 Global Biomaterials Market Outlook, By Polyester (2021-2030) ($MN)
  • Table 14 Global Biomaterials Market Outlook, By Silicone Rubber (2021-2030) ($MN)
  • Table 15 Global Biomaterials Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 16 Global Biomaterials Market Outlook, By Polyetheretherketone (2021-2030) ($MN)
  • Table 17 Global Biomaterials Market Outlook, By Other Polymeric Biomaterials (2021-2030) ($MN)
  • Table 18 Global Biomaterials Market Outlook, By Ceramics (2021-2030) ($MN)
  • Table 19 Global Biomaterials Market Outlook, By Calcium Phosphate (2021-2030) ($MN)
  • Table 20 Global Biomaterials Market Outlook, By Zirconia (2021-2030) ($MN)
  • Table 21 Global Biomaterials Market Outlook, By Aluminum Oxide (2021-2030) ($MN)
  • Table 22 Global Biomaterials Market Outlook, By Calcium Sulfate (2021-2030) ($MN)
  • Table 23 Global Biomaterials Market Outlook, By Carbon (2021-2030) ($MN)
  • Table 24 Global Biomaterials Market Outlook, By Glass (2021-2030) ($MN)
  • Table 25 Global Biomaterials Market Outlook, By Natural Biomaterials (2021-2030) ($MN)
  • Table 26 Global Biomaterials Market Outlook, By Hyaluronic Acid (2021-2030) ($MN)
  • Table 27 Global Biomaterials Market Outlook, By Collagen (2021-2030) ($MN)
  • Table 28 Global Biomaterials Market Outlook, By Gelatin (2021-2030) ($MN)
  • Table 29 Global Biomaterials Market Outlook, By Fibrin (2021-2030) ($MN)
  • Table 30 Global Biomaterials Market Outlook, By Cellulose (2021-2030) ($MN)
  • Table 31 Global Biomaterials Market Outlook, By Chitin (2021-2030) ($MN)
  • Table 32 Global Biomaterials Market Outlook, By Alginates (2021-2030) ($MN)
  • Table 33 Global Biomaterials Market Outlook, By Silk (2021-2030) ($MN)
  • Table 34 Global Biomaterials Market Outlook, By Application (2021-2030) ($MN)
  • Table 35 Global Biomaterials Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 36 Global Biomaterials Market Outlook, By Stents (2021-2030) ($MN)
  • Table 37 Global Biomaterials Market Outlook, By Implantable Cardiac Defibrillators (2021-2030) ($MN)
  • Table 38 Global Biomaterials Market Outlook, By Pacemakers (2021-2030) ($MN)
  • Table 39 Global Biomaterials Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 40 Global Biomaterials Market Outlook, By Vascular Grafts (2021-2030) ($MN)
  • Table 41 Global Biomaterials Market Outlook, By Orthopaedic (2021-2030) ($MN)
  • Table 42 Global Biomaterials Market Outlook, By Joint Replacement (2021-2030) ($MN)
  • Table 43 Global Biomaterials Market Outlook, By Knee Replacement (2021-2030) ($MN)
  • Table 44 Global Biomaterials Market Outlook, By Hip Replacement (2021-2030) ($MN)
  • Table 45 Global Biomaterials Market Outlook, By Shoulder Replacement (2021-2030) ($MN)
  • Table 46 Global Biomaterials Market Outlook, By Viscosupplementation (2021-2030) ($MN)
  • Table 47 Global Biomaterials Market Outlook, By Bioresorbable Tissue Fixation (2021-2030) ($MN)
  • Table 48 Global Biomaterials Market Outlook, By Suture Anchors (2021-2030) ($MN)
  • Table 49 Global Biomaterials Market Outlook, By Interference Screws (2021-2030) ($MN)
  • Table 50 Global Biomaterials Market Outlook, By Meniscal Repair Tacks (2021-2030) ($MN)
  • Table 51 Global Biomaterials Market Outlook, By Meshes (2021-2030) ($MN)
  • Table 52 Global Biomaterials Market Outlook, By Spine (2021-2030) ($MN)
  • Table 53 Global Biomaterials Market Outlook, By Spinal Fusion Surgeries (2021-2030) ($MN)
  • Table 54 Global Biomaterials Market Outlook, By Minimally Invasive Fusion Surgeries (2021-2030) ($MN)
  • Table 55 Global Biomaterials Market Outlook, By Motion Preservation & Dynamic Stabilization Surgeries (2021-2030) ($MN)
  • Table 56 Global Biomaterials Market Outlook, By Fracture Fixation Devices (2021-2030) ($MN)
  • Table 57 Global Biomaterials Market Outlook, By Bone Plates (2021-2030) ($MN)
  • Table 58 Global Biomaterials Market Outlook, By Screws (2021-2030) ($MN)
  • Table 59 Global Biomaterials Market Outlook, By Pins (2021-2030) ($MN)
  • Table 60 Global Biomaterials Market Outlook, By Rods (2021-2030) ($MN)
  • Table 61 Global Biomaterials Market Outlook, By Wires (2021-2030) ($MN)
  • Table 62 Global Biomaterials Market Outlook, By Synthetics Bone Grafts (2021-2030) ($MN)
  • Table 63 Global Biomaterials Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 64 Global Biomaterials Market Outlook, By Contact Lenses (2021-2030) ($MN)
  • Table 65 Global Biomaterials Market Outlook, By Intraocular Lenses (2021-2030) ($MN)
  • Table 66 Global Biomaterials Market Outlook, By Functional Replacement of Ocular Tissues (2021-2030) ($MN)
  • Table 67 Global Biomaterials Market Outlook, By Synthetic Corneas (2021-2030) ($MN)
  • Table 68 Global Biomaterials Market Outlook, By Dental (2021-2030) ($MN)
  • Table 69 Global Biomaterials Market Outlook, By Dental Implants (2021-2030) ($MN)
  • Table 70 Global Biomaterials Market Outlook, By Dental Bone Grafts & Substitutes (2021-2030) ($MN)
  • Table 71 Global Biomaterials Market Outlook, By Dental Membranes (2021-2030) ($MN)
  • Table 72 Global Biomaterials Market Outlook, By Tissue Regeneration (2021-2030) ($MN)
  • Table 73 Global Biomaterials Market Outlook, By Plastic Surgery (2021-2030) ($MN)
  • Table 74 Global Biomaterials Market Outlook, By Soft-Tissue Fillers (2021-2030) ($MN)
  • Table 75 Global Biomaterials Market Outlook, By Craniofacial Surgery (2021-2030) ($MN)
  • Table 76 Global Biomaterials Market Outlook, By Wound Healing (2021-2030) ($MN)
  • Table 77 Global Biomaterials Market Outlook, By Wound Closure Devices (2021-2030) ($MN)
  • Table 78 Global Biomaterials Market Outlook, By Surgical Hemostats (2021-2030) ($MN)
  • Table 79 Global Biomaterials Market Outlook, By Internal Tissue Sealants (2021-2030) ($MN)
  • Table 80 Global Biomaterials Market Outlook, By Adhesion Barriers (2021-2030) ($MN)
  • Table 81 Global Biomaterials Market Outlook, By Hernia Meshes (2021-2030) ($MN)
  • Table 82 Global Biomaterials Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 83 Global Biomaterials Market Outlook, By Scaffolds for Regenerative Medicine (2021-2030) ($MN)
  • Table 84 Global Biomaterials Market Outlook, By Biosensing (2021-2030) ($MN)
  • Table 85 Global Biomaterials Market Outlook, By Tailoring of Inorganic Nanoparticles (2021-2030) ($MN)
  • Table 86 Global Biomaterials Market Outlook, By Neurological/Central Nervous System Applications (2021-2030) ($MN)
  • Table 87 Global Biomaterials Market Outlook, By Shunting Systems (2021-2030) ($MN)
  • Table 88 Global Biomaterials Market Outlook, By Cortical Neural Prosthetics (2021-2030) ($MN)
  • Table 89 Global Biomaterials Market Outlook, By Hydrogel Scaffolds for CNS Repair (2021-2030) ($MN)
  • Table 90 Global Biomaterials Market Outlook, By Neural Stem Cell Encapsulation (2021-2030) ($MN)
  • Table 91 Global Biomaterials Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 92 Global Biomaterials Market Outlook, By Drug Delivery Systems (2021-2030) ($MN)
  • Table 93 Global Biomaterials Market Outlook, By Gastrointestinal Applications (2021-2030) ($MN)
  • Table 94 Global Biomaterials Market Outlook, By Bariatric Surgery (2021-2030) ($MN)
  • Table 95 Global Biomaterials Market Outlook, By Urinary Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.